Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)


BACKGROUND Gastrointestinal graft-versus-host disease (GvHD) is a potentially life-threatening complication after allogeneic stem cell transplantation (SCT). Since therapeutic options are still limited, a prophylactic approach seems to be warranted. METHODS In this randomised, double-blind-phase III trial, we evaluated the efficacy of budesonide in the… (More)
DOI: 10.1186/s12876-014-0197-7


6 Figures and Tables